These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 311865)

  • 1. [Immunochemical studies on proteinase inhibitor of co-precipitation after euglobulin fraction of plasma (author's transl)].
    Miyatani K
    Rinsho Byori; 1979; 27(1):57-9. PubMed ID: 311865
    [No Abstract]   [Full Text] [Related]  

  • 2. Protease inhibitor and gastric cancer.
    Tsumoto S; Oyabu H; Kageyama T
    Bull Osaka Med Sch; 1983 Jul; 29(1):18-26. PubMed ID: 6204707
    [No Abstract]   [Full Text] [Related]  

  • 3. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
    Mikami A; Kohno M
    Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood levels of proteinase inhibitors in pregnancy.
    Walker JE; Campbell DM; Ogston D
    Br J Obstet Gynaecol; 1982 Mar; 89(3):208-10. PubMed ID: 6175337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.
    Kluft C
    Haemostasis; 1976; 5(3):136-46. PubMed ID: 12071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human plasma proteinase inhibitors.
    Travis J; Salvesen GS
    Annu Rev Biochem; 1983; 52():655-709. PubMed ID: 6193754
    [No Abstract]   [Full Text] [Related]  

  • 8. [Proteinase inhibitors and fibrinogen split products in patients with malignant diseases (author's transl)].
    Schwarz HP; Aiginger P; Kuzmits R
    Acta Med Austriaca; 1981; 8(1):22-5. PubMed ID: 6165218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic studies on platelet antiproteases.
    Nalli G; Majolino I; Fornasari PM; Cattaneo G; Malamani GD; Almasio P; Piovella F; Ascari E
    Haematologica; 1978 Apr; 63(2):156-62. PubMed ID: 79518
    [No Abstract]   [Full Text] [Related]  

  • 10. Blood levels of proteinase inhibitors in pre-eclampsia.
    Gow L; Campbell DM; Ogston D
    Br J Obstet Gynaecol; 1983 Oct; 90(10):950-2. PubMed ID: 6194812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and experimental studies of the influence of Cl-inactivator on the euglobulin clot lysis time (author's transl)].
    Takeda S; Katoh H; Takaki A; Nouzuka Y; Ohsato K
    Rinsho Ketsueki; 1979 Aug; 20(8):879-85. PubMed ID: 502003
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibitors of serum proteinases].
    Jendryczko A; Drózdz M
    Wiad Lek; 1985 Dec; 38(23):1654-9. PubMed ID: 2421489
    [No Abstract]   [Full Text] [Related]  

  • 13. The interaction of C1-esterase inhibitor and plasmin in human euglobulin.
    Highsmith RF; Burnett CJ; Weirich CJ
    J Lab Clin Med; 1979 Mar; 93(3):459-71. PubMed ID: 155127
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.
    Kluft C; Cooper P; Jie AF; Lowe GD; Forbes CD; Blamey SL; van de Putte LB
    Haemostasis; 1985; 15(2):144-50. PubMed ID: 3874124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma proteinase inhibitors.
    Bodmer JL; Schnebli HP
    Schweiz Med Wochenschr; 1984 Oct; 114(40):1359-63. PubMed ID: 6208604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a proteinase inhibitor from bovine serum with C1-inhibitor activity.
    Van Nostrand WE; Cunningham DD
    Biochim Biophys Acta; 1987 Feb; 923(2):167-75. PubMed ID: 3814612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on immunochemical determination of euglobulin fractionation from serum (author's transl)].
    Miyatani K; Takahata J; Fukui I
    Rinsho Byori; 1973 Nov; 21(11):940-2. PubMed ID: 4205149
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunochemical studies on coagulant, fibrinolytic factors and proteinase inhibitor in inhibitor fraction of plasma (author's transl)].
    Miyatani K
    Rinsho Byori; 1979; 27(4):353-6. PubMed ID: 449088
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum alpha-1 antichymotrypsin is a possible growth inhibitor of Plasmodium falciparum.
    Tharavanij S; Patarapotikul J; Supavan V; Schelp FP; Warrell MJ
    Southeast Asian J Trop Med Public Health; 1983 Sep; 14(3):349-52. PubMed ID: 6197759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.